UTILITY
`PATENT APPLICATION
`TRANSMITTAL
`
`(only for new nonprovisional applications under 37 CFR
`1.53(5))
`
`APPLICATION ELEMENTS
`
`See MPEP Chapter 600 concerning utility patent appilcation
`contents.
`1. [] Fee Transmittal Form (e.g., PTO/SB/17)
`(submit an original and a dupilcate for fee processing)
`2. [] Applicant claims small entity status.
`3. [] Specification [Total Pages 41]
`(Preferred arrangement set forth below)
`- Descriptive Title of the Invention
`- Cross Reference to Related Applications
`- Statement Regarding Fed sponsored R&D
`- Reference to sequence listing, a table, or a
`computer program listing appendix
`- Background of the Invention
`- Brief Summary of the Invention
`- Brief Description of the Drawings (if filed)
`- Detailed Description
`- Claim(s)
`- Abstract of the Disclosure
`
`4. [] Drawing(s)(35 USC 113) [Total Sheets 18]
`5. Oath or Declaration [Total Pages 7]
`a. [] Newly executed (original or copy)
`b. [] Copy from a prior application (37 CFR 1.63(d))
`(for continuation/divisional with Box 18 completed)
`i. [] DELETION OF INVENTOR(S)
`Signed statement attached deleting
`inventor(s) named in the prior application,
`see 37 CFR 1.63(d)(2) and 1.33(b).
`
`Attorney Docket No.
`
`TIP0033USDIV1
`
`First Inventor
`
`Hans Wire Pieter VERMEERSCH et al
`
`Title
`
`PSEUDOPOLYMORPHIC FORMS OF A HIV PROTEASE...
`
`Express Mail Label No.
`
`E-FILED
`ADDRESS TO: Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`7. [] CD-ROM or CD-R in duplicate, large table or
`Computer Program (Appendix)
`
`8. Nucleotide and/or Amino Acid Sequence
`Submission (if applicable, all necessary)
`&[]Computer Readable Form (CRF)
`b.[]Specification Sequence Listing on:
`i. [] CD-ROM or CD-R (2 copies); or
`ii. [] paper
`c.[]Statement verifying identity of above copies
`
`ACCOMPANYING APPLICATION PARTS
`9. [] Assignment Papers (cover sheet & document(s))
`10. [] 37 CFR 3.73(b) Statement [] Power of Attorney
`(when there is an assignee)
`11 .[] English Translation Document (if appficable)
`12.[] Information Disclosure Statement
`(IDS)/PTO-1449 []Copies of IDS Citations
`13.[] Preliminary Amendment
`14.[] Return Receipt Postcard (MPEP 503)
`(Should be specifically itemized)
`15.[] Certified Copy of Priority Document(s)
`(if foreign priority is claimed)
`16. [] Request and Certifications under 35 U.S.C. 122
`(b)(2)(B)(i). Applicant must attach form
`PTO/SB/35 or its equivalent.
`17. [] Other
`
`6. [] Application Data Sheet. See 37 CFR 1.76
`18. [] If a CONTINUING APPLICATION, check appropriate box and supply the requisite information below and in a
`preliminary amendment, or in an Appfication Data Sheet under 37 CFR 1.76:
`[] Continuation [] Divisional [] Continuation-in-Part (CIP)of prior application No.: 10/514,352, filed
`November 12, 2004.
`Prior application information: Examiner Brenda Libby Coleman Art Unit: 1624
`For CONTINUATION or DIVISIONAL APPS only: The entire disclosure of the prior application, from which an
`oath or declaration is supplied under Box 5b, is considered a part of the disclosure of the accompanying
`continuation or divisional application and is hereby incorporated by reference. The incorporation can only be
`relied upon when a portion has been inadvertently omitted from the submitted application parts.
`19. CORRESPONDENCE ADDRESS
`[] Customer Number or Bar Code Label 000027777 or [] Correspondence Address below
`Philip S. Johnson, Esq.
`Name:
`Address:
`Johnson & Johnson
`One Johnson & Johnson Plaza
`New Brunswick, NJ 08933-7003 USA
`20. TELEPHONE CONTACT
`Please direct all telephone calls or telefaxes to at:
`Telephone: (732) 524-1495 Fax: (732) 524-2808
`21SIGNATURE OF APPL ICANT, ATTORNEY, OR AGENT REQ U!RED
`NAME Alana G. Kriegsman Reg. No. 41,747
`
`SIGNATURE
`DATE
`
`/Alana G. Kriegsman/
`August 6, 2009
`
`Lupin Ex. 1007 (Page 1 of 6)
`
`

`
`FEE TRANSMITTAL
`
`Complete if Known
`
`Application Number
`Filing Date
`
`First Named Inventor
`Group Art Unit
`Examiner Name
`Attorney Docket Number
`
`August 6, 2009
`
`VERMEERSCH et al
`
`TIP0033USDIV1
`
`FEE CALCULATION
`
`CLAIMS AS FILED
`
`(1)
`
`FOR:
`
`(2)
`
`(3)
`
`NUMBER FILED NUMBER
`EXTRA
`
`TOTAL CLAIMS
`
`13 - 20 =
`
`INDEPENDENT
`CLAIMS
`
`SEARCH FEE
`
`EXAMINATION FEE
`
`1- 3 =
`
`NA
`
`NA
`
`APPLICATION SIZE
`FEE
`
`0-100 =
`
`0
`
`0
`
`NA
`
`NA
`
`/50
`
`If the specflcation and
`drawings exceed 100
`sheets of paper, the
`application size fee due is
`$250 ($125 for small
`entity) for each additional
`50 sheets or fraction
`thereof. See 25 U.S.C.
`41(a)(1)(G) and 37 CFR
`1.16(s).
`
`MULTIPLE
`DEPENDENT
`CLAIMS
`
`(5)
`
`BASIC FEE
`$330.00
`
`$ 0.00
`
`$ 0.00
`
`$ 540.00
`
`$ 220.00
`
`$ 0.00
`
`(4)
`
`RATE
`
`x 50.00
`
`x200.00
`
`NA
`
`NA
`
`X 250.00 (If the
`specfication and
`drawings exceed
`100 sheets of
`paper, for each
`additional 50
`sheets or fraction
`thereof)
`
`[]
`
`N/A
`
`$360.00
`
`0.00
`
`TOTAL FEES
`
`$1,090.00
`
`METHOD OF PAYMENT
`
`Please charge Deposit Account No. 10-0750/TIP0033USDIV1/AGK in the amount of
`
`$1,090.00. Three copies of this sheet are enclosed.
`
`The Commissioner is hereby authorized to charge any additional fees which may be
`
`required in connection with the filing of this communication, or credit any overpayment, to
`
`Account No. 10-0750/TIP0033USDIV1/AGK.
`
`SUBMITTED B Y:
`Typed or
`Printed Name Evelina Smith
`
`Signature
`
`/Evelina Smith/
`
`Complete (if applicable)
`
`Deposit Account
`Date: August 6,2009 No. 10-0750
`
`Lupin Ex. 1007 (Page 2 of 6)
`
`

`
`Docket No. TIP0033USDIVI
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Applicants :
`
`VERMEERSCH, Hans Wim Pieter, et al
`
`Serial No. : TBA
`
`Art Unit: TBA
`
`Filed
`
`: August 6, 2009
`
`Examiner: TBA
`
`For
`
`: PSEUDOPOLYMORPHIC
`INHIBITOR
`
`FORMS OF A HIV PROTEASE
`
`CERTIFICATE OF ELECTRONIC FILING
`I hereby certify that this correspondence is being
`transmitted via
`The Office Electronic Filing System in accordance with 37
`CFR 1.6(a) (4) .
`Evelina Smith
`
`August 6, 2009
`
`Date of Transmission
`and Signature
`
`Name of Applicant, Assignee, or
`Registered Representative
`!Evel ina Smith/
`
`Signature
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`INFORMATION DISCLOSURE STATEMENT
`
`Dear Sir:
`
`Pursuant to 37 C.F.R. §1.56 and in accordance with 37
`C.F.R. §§1.97-1.98, information relating to the above-identified
`application is hereby disclosed. Inclusion of information in
`this statement is not to be construed as an admission that this
`information is material as that term is defined in 37 C.F.R.
`
`§i. 56 (b) .
`Applicant(s) reserve(s) the right to establish the
`patentability of the claimed invention over any of the
`information provided herewith, and/or to prove that this
`information may not be prior art, and/or to prove that this
`information may not be enabling for the teachings purportedly
`offered.
`
`Lupin Ex. 1007 (Page 3 of 6)
`
`

`
`This statement should not be construed as a representation
`that a search has been made, or that information more material
`to the examination of the present patent application does not
`exist.
`
`[] In accordance with §1.97(b), since this Information
`Disclosure Statement is being filed either within three months
`of the filing date of the above-identified national application
`
`(other than a continued prosecution application under §1.53(d)),
`within three months of the date of entry into the national
`stage of the above identified application as set forth in
`
`§1.491, or before the mailing date of a first Office Action on
`the merits of the above-identified application, or before the
`mailing date of a first Office Action after the filing of a
`
`request for continued examination under §1.114, no additional
`fee is required.
`
`[] In accordance with §I.129(a), this Information
`Disclosure Statement is being filed in connection with [] the
`
`first or []second After Final Submission, therefore:
`[] Statement in Accordance with §1.97(e)
`(attached); or
`Please charge Deposit Account No. i0-
`0750/
`/ the fee of $180.00 as set forth
`in §i. 17 (p) .
`
`[]
`
`[] In accordance with §1.97(c), this Information
`Disc!osure Statement is being filed after the period set forth
`
`in §1.97(b) above but before the mailing date of either a Final
`
`Action under §1.113 or a Notice of Allowance under §1.311, or an
`action that otherwise closes prosecution and that it is
`accompanied by one of:
`
`[]
`
`Statement in Accordance with §1.97(e)
`(attached); or
`
`- 2 -
`
`Lupin Ex. 1007 (Page 4 of 6)
`
`

`
`Please charge Deposit Account No. i0-
`0750/
`/ the fee of $180.00 as set forth
`in §i. 17 (p) .
`
`[] In accordance with §1.97(d), this Information
`Disclosure Statement is being filed after the mailing date of
`
`either a Final Action under §1.113 or a Notice of Allowance
`under §1.311 but before the payment of the Issue Fee.
`Applicant(s) hereby petition(s) for consideration of this
`Information Disclosure Statement. Included are: Statement in
`Accordance with §1.97(e) as set forth below and the fee of
`
`$180.00 as set forth in §l.17(p) .
`
`[] Copies of each of the references listed on the
`attached Form PTO-1449 are enclosed herewith.
`
`[] Copies of references listed on the attached Form PTO-
`1449 are enclosed herewith EXCEPT THAT:
`
`In view of the voluminous nature of references
`[list as appropriate], and the likelihood that
`these references are available to the Examiner,
`copies are not enclosed herewith.
`
`If any of the foregoing publications are not
`available to the Examiner, Applicant will
`endeavor to supply copies at the Examiner’s
`request.
`
`[] Copies of only foreign patent documents and non-
`patent literature are enclosed in accordance with 37 CFR 1.98
`
`(a)(2).
`[] There are no listed references which are not in the
`English language.
`
`- 3 -
`
`Lupin Ex. 1007 (Page 5 of 6)
`
`

`
`[] The relevance of those listed references which are
`not in the English language is as follows:
`
`[] Attached are copies of search report(s) from
`corresponding patent application(s), which are listed on the
`attached Submission Under MPEP 609 D.
`
`[] Attached are the following non-published pending
`patent applications which may be deemed relevant, which are
`listed on the attached Submission Under MPEP 609 D.
`
`Please charge any deficiency or credit any overpayment to
`Deposit Account No. 10-0750/TIP0033USDIVl/AGK.
`
`Respectfully submitted,
`
`/Alana G. Kriegsman/
`
`Alana G. Kriegsman
`Reg. No. 41,747
`Attorney for Applicants
`
`Johnson & Johnson
`One Johnson & Johnson Plaza
`New Brunswick, NJ 08933-7003
`(732) 524-1495
`DATED: August 6, 2009
`
`Lupin Ex. 1007 (Page 6 of 6)